Skip to main content
. 2011 Jan 1;203(1):66–74. doi: 10.1093/infdis/jiq016

Table 5.

Risk factors for prevalent detection of HPV DNA in external genital swabs (A) and anal swabs (B) at enrollment among men who have sex with men

A. External Genital Sites
Risk Factor Prevalent Detection of HPV 6/11/16/18 DNAin External Genital Swabs
Prevalent Detection of Any Tested HPV DNAin External Genital Swabs*
% (no. with infection/no. of subjects) Odds Ratio(95%CI) % (no. with infection/no. of subjects) Odds Ratio(95%CI)
Age
    15–20 15.6 (27/173) 2.0 (1.1–3.7) 24.3 (42/173) 1.3 (0.8–2.1)
    21–-27 9.8 (41/417) 1.0 22.3 (93/417) 1.0
Tobacco use on day 1
    Never used 10.4 (31/297) 1.0 20.9 (62/297) 1.0
    Current user 16.4 (9/55) 1.9 (0.8–4.3) 25.5 (14/55) 1.5 (0.7–3.0)
    Ex-user 11.8 (28/238) 1.0 (0.6–1.7) 24.8 (59/238) 0.9 (0.6–1.4)
Sex history with MALE partners on day 1
Age at first intercourse
    <15 16.1 (9/56) 1.1 (0.4–3.0) 25.0 (14/56) 0.6 (0.3–1.4)
    15–19 11.8 (43/363) 0.8 (0.4–1.7) 23.7 (86/363) 0.8 (0.5–1.3)
    ≥20 10.9 (16/147) 1.0 23.1 (34/147) 1.0
Lifetime sex partners
    ≤1 10.4 (7/67) 1.0 14.9 (10/67) 1.0
    2 12.4 (12/97) 1.1 (0.4–3.1) 23.7 (23/97) 1.9 (0.8–4.6)
    3–6 12.3 (49/400) 1.1 (0.4–2.8) 25.3 (101/400) 2.0 (0.9–4.6)
Frequency of lifetime condom use
    Never 9.7 (3/31) 0.8 (0.2–2.9) 19.4 (6/31) 1.1 (0.4–3.0)
    Less than half of the time 10.3 (6/58) 0.9 (0.3–2.2) 22.4 (13/58) 1.2 (0.6–2.3)
    Always/More than half of the time 12.4 (59/477) 1.0 24.1 (115/477) 1.0
Circumcision
    No 11.5 (38/331) 1.0 26.3 (87/331) 1.0
    Yes 11.6 (30/259) 1.7 (0.9–3.3) 18.5 (48/259) 1.2 (0.7–2.1)
Region
    Australia 7.1 (6/84) 1.0 13.1 (11/84) 1.0
    Europe 17.2 (21/122) 3.2 (1.2–8.6) 31.1 (38/122) 3.3 (1.5–7.0)
    Latin America 13.6 (18/132) 2.3 (0.8–6.3) 36.4 (48/132) 4.4 (2.1–9.3)
    North America 9.1 (23/252) 1.1 (0.4–3.0) 15.1 (38/252) 1.1 (0.5–2.5)
B. Anal Canal
Risk Factor Prevalent Detection of HPV 6/11/16/18 DNA in Anal Swabs
Prevalent Detection of Any Tested HPV DNA in Anal Swabs*
% (no. with infection/no. of subjects) Odds Ratio(95%CI) % (no. with infection/no. of subjects) Odds Ratio(95%CI)
Age
    15–20 21.6 (37/171) 0.9 (0.5–1.4) 34.5 (59/171) 0.7 (0.4–1.1)
    21–27 26.7 (111/416) 1.0 45.7 (190/416) 1.0
Tobacco use on day 1
    Never used 20.3 (60/295) 1.0 36.3 (107/295) 1.0
    Current user 22.2 (12/54) 1.0 (0.5–2.1) 33.3 (18/54) 0.8 (0.4–1.6)
    Ex-user 31.9 (76/238) 1.6 (1.0–2.4) 52.1 (124/238) 1.5 (1.0–2.1)
Sex history with MALE partners on day 1
Age at first intercourse
    <15 23.6 (13/55) 0.7 (0.3–1.5) 47.3 (26/55) 0.8 (0.4–1.6)
    15–19 28.3 (102/360) 1.1 (0.7–1.8) 45.8 (165/360) 1.0 (0.7–1.7)
    ≥20 22.3 (33/148) 1.0 39.2 (58/148) 1.0
Lifetime sex partners
    ≤1 11.8 (8/68) 1.0 17.6 (12/68) 1.0
    2 22.4 (22/98) 2.0 (0.8–5.1) 37.8 (37/98) 2.7 (1.2–6.0)
    3–6 29.9 (118/395) 2.5 (1.0–6.0) 50.4 (199/395) 3.8 (1.8–8.0)
Frequency of lifetime condom use
    Never 16.1 (5/31) 1.0 (0.3–2.9) 35.5 (11/31) 1.5 (0.6–3.8)
    Less than half of the time 22.0 (13/59) 1.0 (0.5–1.9) 32.2 (19/59) 0.8 (0.4–1.4)
    Always/More than half time 27.5 (130/473) 1.0 46.3 (219/473) 1.0
Circumcision
    No 31.0 (101/326) 1.0 50.6 (165/326) 1.0
    Yes 18.0 (47/261) 0.7 (0.4–1.2) 32.2 (84/261) 1.0 (0.6–1.5)
Region
    Australia 31.7 (26/82) 1.0 42.7 (35/82) 1.0
    Europe 34.7 (42/121) 1.1 (0.6–2.0) 61.2 (74/121) 2.1 (1.1–3.7)
    Latin America 30.8 (40/130) 0.9 (0.5–1.6) 56.9 (74/130) 1.7 (1.0–3.1)
    North America 15.7 (40/254) 0.6 (0.3–1.1) 26.0 (66/254) 0.6 (0.3–1.1)

NOTE. CI,confidence interval.

*

HPV 6, 11, 16, 18, 31, 33, 35, 39, 45, 51, 52, 56, 58, and 59. The multivariate logistic regression model was adjusted for geographic area of residence, age, tobacco use, age at first sexual intercourse with a male partner, number of lifetime sexual partners, number of new partners in the past 6 months, and circumcision history.